Groupe d'Etude en Oncologie du Quebec

Titre	PRO-ACTIVE: Comparing The Effectiveness of Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer
Protocole ID	CTO1363
ClinicalTrials.gov ID	NCT03455608
Type(s) de cancer	ORL
Phase
Type étude	Support
Institution	CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS 3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2
Ville	Montréal
Investigateur(trice) principal(e)	Dr Khalil Sultanem
Coordonnateur(trice)	Carolane Blais 514-340-8222 poste 25098
Statut	Fermé
Critètes d'éligibilité	Adults ≥ 18 years of age diagnosed with head and neck malignancy RT treatment planned for curative intent; and Dispositioned to receive external beam radiotherapy dose ≥60 gray to bilateral fields at participating institution
Critètes d'exclusion	Distant metastasis at enrollment; or Prior or planned total laryngectomy; or Moderate/severe dysphagia at enrollment per baseline videofluoroscopy DIGEST grade ≥2 (as graded per central laboratory review)

Groupe d'étude en oncologie du Québec